Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one ...
Despite increased labeling of drugs with pediatric information, most medicines remain available only as pills meant for ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-m ...
Daiichi Sankyo continues to advance its pipeline, offering positive catalysts over the next year. Click here to read why ...
MORE than seven in 10 severely visually impaired people find buying food a challenge – and 71 per cent have avoided it ...
The Trump administration has built up a fleet of warships near Venezuela as American forces keep blowing up small boats ...
Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...
Early evidence links some Alzheimer’s Disease medications to small cognitive gains in children with autism and low IQ, ...
Jaypirca was approved for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were previously treated with a covalent Bruton ...
Eli Lilly's fast-growing blood cancer drug Jaypirca has bagged a new FDA approval as an earlier treatment for relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback